Showing results (201-210 of 261) with videos related to
Sort By:
Pageof 27
Journal of the American College of Cardiology|November 7, 2006
Effects of high-dose atorvastatin on cerebrovascular events in patients with stable coronary disease in the TNT (treating to new targets) studyDavid D Waters, John C LaRosa, Philip Barter, et al.Circulation|April 6, 2018
Triglyceride-Rich Lipoprotein Cholesterol and Risk of Cardiovascular Events Among Patients Receiving Statin Therapy in the TNT TrialAntonio J Vallejo-Vaz, Rana Fayyad, S Matthijs Boekholdt, et al.The American Journal of Cardiology|March 31, 2012
Relation of improvement in estimated glomerular filtration rate with atorvastatin to reductions in hospitalizations for heart failure (from the Treating to New Targets [TNT] study)Jennifer E Ho, David D Waters, Allison Kean, et al.Journal of the American College of Cardiology|May 17, 2008
Intensive lipid-lowering with atorvastatin for secondary prevention in patients after coronary artery bypass surgerySanjiv J Shah, David D Waters, Philip Barter, et al.The American Journal of Cardiology|March 4, 2014
Impact of high-dose atorvastatin therapy and clinical risk factors on incident aortic valve stenosis in patients with cardiovascular disease (from TNT, IDEAL, and SPARCL)Benoit J Arsenault, S Matthijs Boekholdt, Samia Mora, et al.Circulation|March 31, 2012
Determinants of residual risk in secondary prevention patients treated with high- versus low-dose statin therapy: the Treating to New Targets (TNT) studySamia Mora, Nanette K Wenger, David A Demicco, et al.BMJ Global Health|January 21, 2025
Incidence, long-term predictors and progression of chronic kidney disease among African migrants and non-migrants: the transcontinental population-based prospective RODAM cohort studyMuhulo Muhau Mungamba, Felix P Chilunga, Eva L van der Linden, et al.Circulation|September 25, 2002
Effects of atorvastatin on stroke in patients with unstable angina or non-Q-wave myocardial infarction: a Myocardial Ischemia Reduction with Aggressive Cholesterol Lowering (MIRACL) substudyDavid D Waters, Gregory G Schwartz, Anders G Olsson, et al.Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|January 14, 2022
Recovery of dialysis patients with COVID-19: health outcomes 3 months after diagnosis in ERACODAMarc H Hemmelder, Marlies Noordzij, Priya Vart, et al.Langenbeck'S Archives of Surgery|November 12, 2018
Safety and efficacy of subtotal or total parathyroidectomy for patients with secondary or tertiary hyperparathyroidism in four academic centers in the NetherlandsWillemijn Y van der Plas, Rorderick R Dulfer, Ezra Y Koh, et al.Pageof 27